Skip to content ↓

In the Media

Displaying 15 news clips on page 293

Boston Globe

Alumna Farah Alibay PhD ’14 speaks with Boston Globe reporter Charlie McKenna about her work with the Ingenuity helicopter, an experiment aimed at achieving flight on Mars. “If we are able to demonstrate flight, it could open up possibilities, incredible possibilities for future missions that could be scout helicopters for rovers or science helicopters for exploring Mars,” says Alibay. “It just opens up aerial explorations of Mars, then possibly other planets, too.”

McGonigal's Chronicles: Making Montana Connections

McGonigal’s Chronicles, a new podcast celebrating extraordinary people with Montana connections, recently launched with an appearance by Professor Dava Newman. In conversation with the host, Tim McGonigal of Montana Television Network, Newman discusses growing up in Big Sky Country, her excitement about becoming director of the MIT Media Lab, and the importance of role models. “All little folks have a great dream, and I think it’s all of our responsibility then to help empower them, help their dreams come true,” says Newman.

New Scientist

Researchers from MIT and the Indian Institute of Technology Madras have developed a new technique to grow and culture human brain tissue in an inexpensive bioreactor, writes Christa Lesté-Lasserre for New Scientist. The researchers have now “reported the growth of a brain organoid over seven days. This demonstrates that the brain cells can thrive inside the chip.”

Boston Globe

A group of MIT scientists has announced a new plan, called the Future Founders Initiative, aimed at addressing gender inequities in the biotech industry, reports Anissa Gardizy for The Boston Globe. “If we can’t advance discoveries at the same rate for women and men, that means there are drugs, therapies, devices, and diagnostics that are not getting to where they can actually benefit people,” says President Emerita Susan Hockfield. “If as a region we want to continue to lead the world, the best thing to do is not squander our resources.”

STAT

A team from MIT has been named a co-winner of this year’s STAT Madness, a bracket-style competition for biomedical research. The team, led by visiting scientist Junwei Li and Prof. Gio Traverso, “developed a solution that, once inside the small intestine, undergoes a reaction and coats it with a temporary adhesive,” which could be used “to make drug delivery more efficient," reports Rebecca Sohn for STAT.

The Washington Post

Senior Research Scientist Stephanie Seneff co-authored an opinion piece for The Washington Post, which examines how the high level of herbicide chemicals found in Florida waterways is contributing to a record number of manatee deaths. “If we want to stop manatees from starving, we have to stop using this harmful chemical on our crops, on our lawns and in our waterways,” they conclude. 

The Atlantic

Chris Woolston highlights research from Prof. Laura Schulz as he examines the benefits of playtime for The Atlantic. “Pretending to fight dragons won’t make you any better at fighting dragons,” says Schulz, but when children play pretend, “they’re setting up a cognitive space where they can create a problem and then solve it.”

BBC News

Chloe Smith, a student at Elliot Hudson College in Leeds, speaks with the BBC about being accepted to MIT. "I think through hard work and basically having a plan and thinking no matter what people say even though it seems like shooting for the stars, if you are willing to look for the opportunities you can follow them and achieve amazing things,” says Smith.

E&T

A new study by researchers from the Singapore-MIT Alliance for Research and Technology (SMART) finds that ride-sharing services can lead to increased congestion, both in intensity and duration, reports E&T. “While mathematical models in prior studies showed that the potential benefit of on-demand shared mobility could be tremendous, our study suggests that translating this potential into actual gains is much more complicated in the real world,” says Prof. Jinhua Zhao.

Fast Company

Fast Company reporter Elizabeth Segran spotlights how CSAIL researchers have crafted a new smart fabric embedded with sensors that can sense pressure from the person wearing it. “Sensors in this new material can be used to gather data about people’s posture and body movements,” writes Segran. “This could be useful in a variety of settings, including athletic training, monitoring the health of elderly patients, and identifying whether someone has fallen over.”

Mashable

CSAIL researchers have developed a new material with embedded sensors that can track a person’s movement, reports Mashable. The clothing could “track things like posture or give feedback on how you’re walking.”

Financial Times

In a letter to the Financial Times, graduate student Daniel Aronoff writes that “the US may avoid inflation, but it cannot escape the consequences of increased government spending, for good or ill.”

Wired

Wired reporter Will Knight writes that MIT researchers have found that many of the key AI data sets used to train algorithms could contain many errors. “What this work is telling the world is that you need to clean the errors out,” says graduate student Curtis Northcutt. “Otherwise the models that you think are the best for your real-world business problem could actually be wrong.”

Women in Economics Podcast

Prof. Nancy Rose speaks with Mary Suiter of the Women in Economics podcast about what led her to study economics, her time working at the U.S. Department of Justice, and why teaching and mentoring are so important to her. “A couple of extraordinarily influential teachers are the reason I’m an economist today, and so part of it is just trying to pass on my enthusiasm for economics and my appreciation for what it’s enabled me to do to students,” says Rose.

The Atlantic

A new study by Prof. Jeffrey Harris finds that the extensive research invested in developing a vaccine for HIV has contributed to the successful development of Covid-19 vaccines, writes Derek Thompson for The Atlantic. Nearly 90 percent of COVID-19 vaccines that made it to clinical trials used technology that “could be traced back to prototypes tested in HIV vaccine trials,” Harris found.